Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Jinggong Hongyuan

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$19M
Portfolio companies 1
Rounds per year 0.12
Lead investments 0
Key employees Soon

Areas of investment

  • Therapeutics
  • Biotechnology
  • Clinical Trials
  • Pharmaceutical
  • Health Diagnostics
Summary

In 2016 was created Jinggong Hongyuan, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Beijing. The venture was found in Asia in China.

The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2017.

The usual cause for the fund is to invest in rounds with 6 partakers. Despite the Jinggong Hongyuan, startups are often financed by General Technology Venture Capital. The meaningful sponsors for the fund in investment in the same round are ZGC Group, Shanghai Creation Investment, Proxima Ventures Ltd.

Among the various public portfolio startups of the fund, we may underline Cygnus Biosciences For fund there is a match between the location of its establishment and the land of its numerous investments - China. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Therapeutics.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Jinggong Hongyuan:
Typical Co-investors
Jinggong Hongyuan is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Jinggong Hongyuan:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Anchorage Capital Partners Australia, New South Wales, Sydney
BlueJay Syndicate Baltimore, Maryland, United States
BULB Japan Japan, Tokyo
Chicago Early Growth Ventures (CEGV) Chicago, Illinois, United States
Financial Academy Japan, Tokyo
Gemini Capital Management Fund Seattle, United States, Washington
Goodwood Capital Fund Canada, Ontario, Toronto
Heartland Farms Hancock, United States, Wisconsin
JHF Investment Beijing, Beijing, China
Kesheng Chuangtou China, Shanghai
NYC Media Lab Brooklyn, New York, United States
Oaktree Specialty Lending Corp. New York, United States, White Plains
Paradice Investment Management -
Paras Aerospace -
Ricebank China, Hangzhou, Zhejiang
Rotor Capital Partners Delaware, Lewes, United States
SIG Global India Fund -
Staley Capital Massachusetts, United States, Wellesley
XLHEALTH Berlin, Berlin, Germany

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Cygnus Biosciences

Biotechnology
Clinical Trials
Health Diagnostics
Pharmaceutical
Therapeutics
$19M14 Nov 2017 Changping District, Beijing, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Jinggong Hongyuan?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 19M
Rounds per year 0.12
Peak activity year 2017
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Cygnus Biosciences

Biotechnology
Clinical Trials
Health Diagnostics
Pharmaceutical
Therapeutics
$19M14 Nov 2017 Changping District, Beijing, China
Crunchbase icon

Content report

The following text will be sent to our editors: